A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 7, 2001, Pages 503-510

  Strandberg, K ^a   Bhiladvala, P ^a   Holm, J ^a   Stenflo, Johan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activated protein C protein C inhibitor complex; Case control study; Immunofluorometric assay; Myocardial infarction

Indexed keywords

ACTIVATED PROTEIN C; CREATINE KINASE MB; PLASMINOGEN ACTIVATOR INHIBITOR 3; THROMBIN ANTITHROMBIN COMPLEX; TROPONIN I;

ACUTE DISEASE; ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; CORONARY DISEASE; CREATINE KINASE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FLUOROIMMUNOASSAY; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE HYDROLASES; PROTEIN C; PROTEIN C INHIBITOR; ROC CURVE; TROPONIN I;

EID: 0034750116     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200110000-00001     Document Type: Article

References (22)

1. Blood coagulation
2. Endothelial protein C receptor
3. Protein C inhibitor: Structure and function
4. Activated protein C inhibitor
5. Physiological inhibition of human activated protein C by a-1-antitrypsin
6. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states
7. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease
8. Identification of active tissue factor in human coronary atheroma
9. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
10. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes
11. Biochemical markers of myocardial damage
12. Protein C activation following coronary artery occlusion in the in situ porcine heart
13. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction
14. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction
15. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's
16. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism
17. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: Use of a catcher antibody specific for the complexed/cleaved form of the inhibitor
18. Software for illustrative presentation of basic clinical characteristics of laboratory tests - Graph ROC for Windows
19. Acute myocardial infarction
20. Markers of activated coagulation for early diagnosis of acute myocardial infarction
21. Failure of thrombin generation markers to triage patients presenting with chest pain
22. Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries